High‐resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China

References

• Nan H., Qiao Q., Dong Y., Gao W., Tang B., Qian R., et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006; 33: 1346–50
   PubMed Web of Science ®Google Scholar
• Hoskison T. K., Wortmann R. L. Advances in the management of gout and hyperuricaemia. Scand J Rheumatol 2006; 35: 251–60
   PubMed Web of Science ®Google Scholar
• Lippi G., Montagnana M., Franchini M., Favaloro E. J., Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008; 392: 1–7
   PubMed Web of Science ®Google Scholar
• Strasak A. M., Kelleher C. C., Brant L. J., Rapp K., Ruttmann E., Concin H., et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21‐year follow‐up study. Int J Cardiol 2008; 125: 232–9
   PubMed Web of Science ®Google Scholar
• Scott J. T. Gout. Bailliere's Clin Rheumatol 1987; 1: 525–46
   PubMedGoogle Scholar
• Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S. H., et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417: 447–52
   PubMed Web of Science ®Google Scholar
• Hediger M. A., Johnson R. J., Miyazaki H., Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005; 20: 125–33
   PubMed Web of Science ®Google Scholar
• Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S., et al. Molecular identification of a renal urate‐anion exchanger that regulates blood urate levels. Nature 2002; 417: 447–52
   PubMed Web of Science ®Google Scholar
• Iwai N., Mino Y., Hosoyamada M., Tago N., Kokubo Y., Endou H. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 2004; 66: 935–44
   PubMed Web of Science ®Google Scholar
• Vázquez‐Mellado J., Jiménez‐Vaca A. L., Cuevas‐Covarrubias S., Alvarado‐Romano V., Pozo‐Molina G., Burgos‐Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology 2007; 46: 215–19
   PubMed Web of Science ®Google Scholar
• Reed G. H., Kent J. O., Wittwer C. T. High‐resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 2007; 8: 597–608
   PubMed Web of Science ®Google Scholar
• Vandersteen J. G., Bayrak‐Toydemir P., Palais R. A., Wittwer C. T. Identifying common genetic variants by high‐resolution melting. Clin Chem 2007; 53: 1191–8
   PubMed Web of Science ®Google Scholar
• Fang J., Alderman M. H. Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow‐up Study, 1971–1992. National Health and Nutrition Examination Survey. J Am Med Assoc 2000; 283: 2404–10
   PubMed Web of Science ®Google Scholar
• Ichida K., Hosoyamada M., Hisayome I., Enomoto A., Hikita M., Endou H., et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan: influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15: 164–73
   PubMed Web of Science ®Google Scholar
• Tanaka M., Itoh K., Matsushita K., Wakita N., Adachi M., Nonoguchi H. Two male siblings with hereditary renal hypouricemia and exercise‐induced ARF. Am J Kidney Dis 2003; 42: 1287–92
   PubMed Web of Science ®Google Scholar
• Shima Y., Teruya K., Ohta H. Association between intronic SNP in urate‐anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006; 79: 2234–7
   PubMed Web of Science ®Google Scholar
• Graessler J., Graessler A., Unger S., Kopprasch S., Tausche A. K., Kuhlisch E., et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54: 292–300
   PubMedGoogle Scholar
• Graham R., Liew M., Meadows C., Lyon E., Wittwer C. T. Distinguishing different DNA heterozygotes by high‐resolution melting. Clin Chem 2005; 51: 1295–8
   PubMed Web of Science ®Google Scholar
• Vandersteen J. G., Bayrak‐Toydemir P., Palais R. A., Wittwer C. T. Identifying common genetic variants by high‐resolution melting. Clin Chem 2007; 53: 1191–8
   PubMed Web of Science ®Google Scholar
• Montgomery J., Wittwer C. T., Palais R., Zhou L. Simultaneous mutation scanning and genotyping by high‐resolution DNA melting analysis. Nat Protoc 2007; 2: 59–66
   PubMed Web of Science ®Google Scholar
• Hung C. C., Lee C. N., Chang C. H., Jong Y. J., Chen C. P., Hsieh W. S., et al. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high‐resolution melting analysis. Clin Biochem 2008; 41: 162–6
   PubMedGoogle Scholar
• Liyanage K. E., Hooper A. J., Defesche J. C., Burnett J. R., van Bockxmeer F. M. High‐resolution melting analysis for detection of familial ligand‐defective apolipoprotein B‐100 mutations. Ann Clin Biochem 2008; 45((Pt 2))170–6
   PubMedGoogle Scholar
• Bastien R., Lewis T. B., Hawkes J. E., Quackenbush J. F., Robbins T. C., Palazzo J., et al. High‐throughput amplicon scanning of the TP53 gene in breast cancer using high‐resolution fluorescent melting curve analyses and automatic mutation calling. Hum Mutat 2008; 29: 757–64
   PubMed Web of Science ®Google Scholar